我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。
开放获取期刊获得更多读者和引用 700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
审查
Emerging Therapies in Persistent Human Papillomavirus Infections
研究文章
Evaluating the Efficacy of Tocilizumab in Moderate to Severe COVID-19 with Progressive Illness despite Steroids: Identifying the Optimal Timing of Its Administration in C3G Study
会议论文集
Research Contribution and Achievement
Tropical Medicine 2020
Young Scientist Awards for Infection Control 2020
评论文章
Clinical Evidence of Favipiravir in the Management of COVID-19 Disease
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi